Henan Lingrui Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Henan Lingrui Pharmaceutical has a total shareholder equity of CN¥2.9B and total debt of CN¥28.1M, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are CN¥5.0B and CN¥2.0B respectively. Henan Lingrui Pharmaceutical's EBIT is CN¥654.2M making its interest coverage ratio -28.6. It has cash and short-term investments of CN¥1.5B.
Key information
1.0%
Debt to equity ratio
CN¥28.10m
Debt
Interest coverage ratio | -28.6x |
Cash | CN¥1.53b |
Equity | CN¥2.94b |
Total liabilities | CN¥2.04b |
Total assets | CN¥4.98b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600285's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥2.0B).
Long Term Liabilities: 600285's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥64.2M).
Debt to Equity History and Analysis
Debt Level: 600285 has more cash than its total debt.
Reducing Debt: 600285's debt to equity ratio has reduced from 11.9% to 1% over the past 5 years.
Debt Coverage: 600285's debt is well covered by operating cash flow (2764.5%).
Interest Coverage: 600285 earns more interest than it pays, so coverage of interest payments is not a concern.